Last reviewed · How we verify

NCT02651818: SOLOIST

Changes in Quality of Life Following Surgical Treatment of Benign Non-toxic Goiter

Completed Last updated 15 May 2018
What this trial tests

trial testing Thyroidectomy in Goiter in 104 participants. Completed in 24 October 2017.

Timeline
30 October 2014
Primary endpoint
24 October 2017
24 October 2017

Quick facts

Lead sponsorUniversity of Southern Denmark
StatusCompleted
Study typeOBSERVATIONAL
Enrollment104
Start date30 October 2014
Primary completion24 October 2017
Estimated completion24 October 2017
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern Denmark

Who can join

Adults 20 to 80, any sex, with Goiter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to investigate the influence of surgical treatment on benign non-toxic goiter on the disease specific quality of life evaluated 6 months after thyroid surgery. All investigations follow already scheduled treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Thyroidectomy

Trials testing the same drug.

Other recruiting trials for Goiter

Currently open trials in the same condition.

Other University of Southern Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02651818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing